B. Storer

Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation

Roland B. Walter, Boglarka Gyurkocza, B. Storer et al. · Leukemia · 2014 · 211 citations · Full text

Hematological Malignancy, Transplantation, Marrow Transplantation +8

Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer.

Joan H. Schiller, B. Storer, K D Tutsch et al. · Journal of Clinical Oncology · 1994 · 136 citations

Anaplastic Wilms' tumor: clinical and pathologic studies.

Jeffrey Bonadio, B. Storer, Patricia Norkool et al. · Journal of Clinical Oncology · 1985 · 126 citations

Second National Wilms, Anaplastic Wilms, Tumoral Pathology +12

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia

Ron Ram, Rainer Storb, Brenda M. Sandmaier et al. · Haematologica · 2011 · 100 citations · Full text

Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study

Joseph Pidala, Georgia B. Vogelsang, X. Chai et al. · Haematologica · 2011 · 91 citations · Full text